The Jubilant Bhartia Group on July 23 announced that group company Jubilant Beverages closed the acquisition of a 40% stake in Hindustan Co...

Jubilant Bhartia Group's promoters are selling minority stakes in listed companies to raise ₹2,000 crore for partially funding the acquisit...

Top brokerages issue ratings and targets for key stocks: Motilal Oswal upgrades HDFC Life to buy; Jefferies reaffirms buy for Sun Pharma; U...

Results that will be out on January 30 include Larsen & Toubro, Bajaj Finserv, Tech Mahindra, Bharat Petroleum Corporation, Bajaj Holdings ...

While the term loan and bonds aggregate to USD 350 million, about Rs 2,787 crore, the company is raising another tranche of USD 50 million ...

While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Phar...

According to the USFDA, the company is recalling the affected lot for being "Superpotent". The affected lot has been manufactured at Lupin'...

Jubilant Life Sciences Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 12571.26 Crore) operating in Ph...

Sharp stock price correction, strong growth rates, focus on the growing speciality pharma segment, a bouquet of niche products, among other...

Shares of Jubilant FoodWorks opened at Rs 1341.95 on BSE against its previous closing of Rs 1303.25.

Better than expected 4th quarter results, improving pharma business, launch of new products, debt reduction and reasonable valuations have ...

The acquisition will be funded through JPL's internal accruals and is likely to be earnings accretive in the first full year of operations,...

A 65% y-o-y increase in net profit, approvals for new generic drug applications, reduction in debt, and resonable valuations have made the ...

Jubilant Generics Inc had commenced the open offer to acquire all outstanding shares of the US-based Cadista Holdings Inc in November.

Mumbai-based Sun Pharma has made it to the top of the domestic drug makers’ leaderboard through overseas acquisitions and quadrupling of re...

The company's board has approved a proposal to transfer its active pharmaceutical ingredient and dosage form business to its Singapore-base...

Jubilant Life is quoting at a deep discount to its peers for the past few years because of its volatile earnings and high leverage.